Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
PaperCitations, authors & open-access status
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 794 citations, 2018 year and closed oa status.
794
Citations
2018
Year
closed
OA Status